CD19 and systemic sclerosis: B cells in TSK/+ mice that resemble human SSc symptoms showed lower stimulation thresholds with constitutive phosphorylation of CD19, increased Ca2+ release upon anti-CD19 activation, and enhanced IL-6 and IgG productions.